Incomplete Excisions of Melanocytic Lesions: Rates and Risk Factors

Authors

  • Sofia Berglund
  • Eva Johansson Backman
  • Zahra Baldawi
  • Linda Horn
  • Rebecca Arbin Borsiin
  • Michelle Marjanovic
  • Thea Christoffersson
  • Martin Gillstedt
  • John Paoli Department of Dermatology and Venereology, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden

DOI:

https://doi.org/10.2340/00015555-3784

Keywords:

incomplete excision, surgery, melanocytic lesion, melanoma, naevus

Abstract

Incomplete excisions of melanocytic lesions occur despite the intention of complete removal. The aim of this study was to determine the incomplete excision rates for benign and malignant melanocytic lesions and the associated risk factors. Demographic, clinical, and histo­pathological data possibly associated with incomplete excision were collected from 2,782 consecutive excisions between 2014 and 2015. Of these, 269 melanocytic lesions (9.7%) were incompletely excised. Multivariate analysis revealed the following risk factors for significantly higher incomplete excision rates: lesions located in the head and neck area (odds ratio (OR) 3.95, 95% confidence interval (95% CI) 2.35–6.65), surgery performed by general practitioners (OR 3.01, 95% CI 2.16–4.19), the use of a punch excision technique (OR 2.83, 95% CI 1.96–4.08), and excision of non-dysplastic naevi (OR 1.58, 95% CI 1.11–2.23). In conclusion, more caution should be taken when excising melanocytic lesions in the head and neck area, general practitioners require more surgical training, and punch excisions of melanocytic lesions should be avoided.

Downloads

Download data is not yet available.

References

Eriksson T, Tinghög G. Societal cost of skin cancer in Sweden in 2011. Acta Derm Venereol 2015; 95: 347-348.

DOI: https://doi.org/10.2340/00015555-1938

Guy GP, Jr., Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC. Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030. MMWR Morb Mortal Wkly Rep 2015; 64: 591-596.

Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, et al. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer 2018; 92: 108-118.

DOI: https://doi.org/10.1016/j.ejca.2017.12.024

National Cancer Control Indicators (NCCI) - Cancer Australia (Incidence, by sex, 1982-2019 melanoma); 2019 [cited 2020 Nov 12]. Available from: https://ncci.canceraustralia.gov.au/diagnosis/cancer-incidence/cancer-incidence.

NORDCAN. Cancer incidence, mortality, prevalence and prediction in the Nordic Countries; 2019 [cited 2020 Nov 12]. Available from http://www-dep.iarc.fr/NORDCAN/SW/frame.asp or http: //www-dep.iarc.fr/NORDCAN/SW/StatsFact.asp?cancer=310&country=0.

Confederation of Regional Cancer Centers in Sweden. [National guidelines - Malignant melanoma]; 2020 [cited 2020 Nov 12]. Available from: http://www.cancercentrum.se/samverkan/cancerdiagnoser/hud-och-ogon/vardprogram/.

European Dermatology Forum. Guideline on the diagnosis and treatment of melanoma; 2012 [cited 2020 Nov 12]. Available from: https: //www.edf.one.

NCCN - National Comprehensive Cancer Network; 2020 [cited 2020 Nov 12]. Available from: https://www.nccn.org

Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald JE, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2019; 80: 208-250.

DOI: https://doi.org/10.1016/j.jaad.2018.08.055

Lindelöf B, Hedblad MA, Ringborg U. [Nevus or malignant melanoma? Correct diagnostic competence results in lower costs]. Lakartidningen 2008; 105: 2666-2669 (in Swedish).

Petty AJ, Ackerson B, Garza R, Peterson M, Liu B, Green C, et al. Meta-analysis of number needed to treat for diagnosis of melanoma by clinical setting. J Am Acad Dermatol 2020; 82: 1158-1165.

DOI: https://doi.org/10.1016/j.jaad.2019.12.063

Moscarella E, Pampena R, Palmiotti G, Bonamonte D, Brancaccio G, Piccolo V, et al. A meta-analysis on the influence of partial biopsy of primary melanoma on disease recurrence and patient survival. J Eur Acad Dermatol Venereol 2020; 34: 279-284.

DOI: https://doi.org/10.1111/jdv.15903

Fleming NH, Egbert BM, Kim J, Swetter SM. Reexamining the threshold for reexcision of histologically transected dysplastic nevi. JAMA Dermatol 2016; 152: 1327-1334.

DOI: https://doi.org/10.1001/jamadermatol.2016.2869

King R, Hayzen BA, Page RN, Googe PB, Zeagler D, Mihm MC, Jr. Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol 2009; 22: 611-617.

DOI: https://doi.org/10.1038/modpathol.2009.22

Botella-Estrada R, Nagore E, Sopena J, Cremades A, Alfaro A, Sanmartín O, et al. Clinical, dermoscopy and histological correlation study of melanotic pigmentations in excision scars of melanocytic tumours. Br J Dermatol 2006; 154: 478-484.

DOI: https://doi.org/10.1111/j.1365-2133.2005.07105.x

Elmore JG, Barnhill RL, Elder DE, Longton GM, Pepe MS, Reisch LM, et al. Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study. BMJ 2017; 357: j2813.

DOI: https://doi.org/10.1136/bmj.j2813

Bakhai M, Hopster D, Wakeel R. A retrospective study comparing the accuracy of prehistology diagnosis and surgical excision of malignant melanomas by general practitioners and hospital specialists. Clin Exp Dermatol 2010; 35: 63-67.

DOI: https://doi.org/10.1111/j.1365-2230.2009.03507.x

Haw WY, Rakvit P, Fraser SJ, Affleck AG, Holme SA. Skin cancer excision performance in Scottish primary and secondary care: a retrospective analysis. Br J Gen Pract 2014; 64: e465-e470.

DOI: https://doi.org/10.3399/bjgp14X680929

Herd RM, Hunter JA, McLaren KM, Chetty U, Watson AC, Gollock JM. Excision biopsy of malignant melanoma by general practitioners in south east Scotland 1982-91. BMJ 1992; 305: 1476-1478.

DOI: https://doi.org/10.1136/bmj.305.6867.1476

Khorshid SM, Pinney E, Bishop JA. Melanoma excision by general practitioners in north-east Thames region, England. Br J Dermatol 1998; 138: 412-417.

DOI: https://doi.org/10.1046/j.1365-2133.1998.02116.x

Murchie P, Sinclair E, Lee AJ. Primary excision of cutaneous melanoma: does the location of excision matter. Br J Gen Pract 2011; 61: 131-134.

DOI: https://doi.org/10.3399/bjgp11X556272

Zgraj O, Taczanowska-Niemczuk A, Gorecki W. Facial location and operating room environment are the risk factors for incomplete excision of melanocytic Nevi. Eur J Pediatr Surg 2019; 29: 458-461.

DOI: https://doi.org/10.1055/s-0038-1672145

Miller CJ, Shin TM, Sobanko JF, Sharkey JM, Grunyk JW, Elenitsas R, et al. Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas. J Am Acad Dermatol 2017; 77: 333-340.e331.

DOI: https://doi.org/10.1016/j.jaad.2017.03.025

Zhang J, Miller CJ, Sobanko JF, Shin TM, Etzkorn JR. Frequency of and factors associated with positive or equivocal margins in conventional excision of atypical intraepidermal melanocytic proliferations (AIMP): a single academic institution cross-sectional study. J Am Acad Dermatol 2016; 75: 688-695.

DOI: https://doi.org/10.1016/j.jaad.2016.05.034

Hilari H, Llorca D, Traves V, Villanueva A, Serra-Guillén C, Requena C, et al. Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases. Actas Dermosifiliogr 2012; 103: 614-623.

DOI: https://doi.org/10.1016/j.ad.2011.12.009

Mills JK, White I, Diggs B, Fortino J, Vetto JT. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma. Am J Surg 2013; 205: 585-590; discussion 590.

DOI: https://doi.org/10.1016/j.amjsurg.2013.01.023

Goulding JM, Levine S, Blizard RA, Deroide F, Swale VJ. Dermatological surgery: a comparison of activity and outcomes in primary and secondary care. Br J Dermatol 2009; 161: 110-114.

DOI: https://doi.org/10.1111/j.1365-2133.2009.09228.x

Murchie P, Delaney EK, Thompson WD, Lee AJ. Excising basal cell carcinomas: comparing the performance of general practitioners, hospital skin specialists and other hospital specialists. Clin Exp Dermatol 2008; 33: 565-571.

DOI: https://doi.org/10.1111/j.1365-2230.2008.02710.x

Salmon P, Mortimer N, Rademaker M, Adams L, Stanway A, Hill S. Surgical excision of skin cancer: the importance of training. Br J Dermatol 2010; 162: 117-122.

DOI: https://doi.org/10.1111/j.1365-2133.2009.09548.x

Hansen C, Wilkinson D, Hansen M, Soyer HP. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners. Arch Dermatol 2009; 145: 1253-1260.

DOI: https://doi.org/10.1001/archdermatol.2009.270

van Rijsingen MC, Vossen R, van Huystee BE, Gorgels WJ, Gerritsen MJ. Skin tumour surgery in primary care: do general practitioners need to improve their surgical skills? Dermatology 2015; 230: 318-323.

DOI: https://doi.org/10.1159/000371812

Zakhem GA, Terushkin V, Mu EW, Polsky D, Meehan SA. Margin assessment for punch and shave biopsies of dysplastic nevi. J Drugs Dermatol 2018; 17: 810-812.

Published

2021-03-23

How to Cite

Berglund, S., Johansson Backman, E., Baldawi, Z., Horn, L., Arbin Borsiin, R., Marjanovic, M., Christoffersson, T., Gillstedt, M., & Paoli, J. (2021). Incomplete Excisions of Melanocytic Lesions: Rates and Risk Factors. Acta Dermato-Venereologica, 101(3), adv00421. https://doi.org/10.2340/00015555-3784